Right-To-Try Bill Gets Another Shot In The House Next Week

The legislation, which has faltered in its way through the Legislature, will necessitate the FDA to work harder to protect patients, FDA Commissioner Scott Gottlieb says. In other news, House Speaker Paul Ryan (R-Wis.) says there's a compromise in the works for a controversial bill that addresses drug pricing; pharma companies may have to start listing their prices in ads; a look at what happens next with Vermont's importation law; and more.

from Kaiser Health News https://ift.tt/2IOGLIm